Table 6.
Correlations between the use of certain classes of medication and clinical symptoms and the IENFD in the lower leg.
| Medication | Questionnaire (CC; p value) | |||
|
| ||||
| No medication | STAI (0.18; 0.02) | |||
|
| ||||
| Weak opioid | GCPS disability due to pain (−0.16; 0.03) | |||
|
| ||||
| Strong opioid | O' Leary (0.23; 0.005) | |||
|
| ||||
| NSAID | NPSI (0.17; 0.02) | GCPS grade (0.19; 0.01) | ADS (0.2; 0.01) | |
|
| ||||
| SNRI | Pain Catastrophizing Scale (0.18; 0.02) | FIQ (0.016; 0.04) | O′ Leary (−0.2; 0.01) | IENFD lower leg (−0.25; 0.001) |
|
| ||||
| Muscle relaxant | GCPS disability due to pain (−0.15; 0.04) | ADS (−0.1; 0.04) | ||
|
| ||||
| Guaifenesin | IENFD lower leg (−0.2; 0.01) | |||
|
| ||||
| Flupirtine | Paresthesia (0.2; 0.01) | |||